Episode

Pediatric Acute Leukemias: Focus on clinical trials for treatment

Podcast
Treating Blood Cancers
Published
Sep 19, 2025
Duration seconds
2287
Processing state
not_requested
Canonical source
https://treatingbloodcancers.org/e106/?utm_source=rss&utm_medium=rss&utm_campaign=e106
Audio
https://media.blubrry.com/treating_blood_cancers/content.blubrry.com/treating_blood_cancers/TBC_E106-Dr_Tasian-Pediatric_Leukemia_mixdown_Production_1.mp3
JSON
/v1/public/podcasts/treating-blood-cancers-14318/episodes/pediatric-acute-leukemias-focus-on-clinical-trials-for-treatment
Markdown
/podcast/treating-blood-cancers-14318/pediatric-acute-leukemias-focus-on-clinical-trials-for-treatment.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/treating-blood-cancers-14318/episodes/pediatric-acute-leukemias-focus-on-clinical-trials-for-treatment/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/treating-blood-cancers-14318/pediatric-acute-leukemias-focus-on-clinical-trials-for-treatment.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Ann Collins, PA, Blood Cancer United, Washington, DC, Kelly Laschinger, MSN, RN, CPNP, CPHON, Blood Cancer United, Washington, DC, Sarah K. Tasian, MD, Children’s Hospital of Philadelphia, Philadelphia, PA Recorded on September 9, 2025 Ann Collins, PA Project Leader, Pediatric Acute Leukemia Master Clinical Trial (PedAL) Blood Cancer United Washington, DC Kelly Laschinger, MSN, RN, CPNP, CPHON Director, Clinical Trial Support Center Blood Cancer United Washington, DC Sarah K. Tasian, MD Blood Cancer United PedAL Master Clinical Trial Lead Associate Professor of Pediatrics, University of Pennsylvania School of Medicine Chief of Hematologic Malignancies Program, Children’s Hospital of Philadelphia Philadelphia, PA Join us for our first episode as Blood Cancer United! In this episode, Dr. Sarah Tasian, from Children’s Hospital of Philadelphia, and Ann Collins and Kelly Laschinger, from Blood Cancer United, join us for an in-depth discussion on pediatric acute leukemias. The conversation delves into the latest therapies, treatment challenges, and the complex realities of long-term survivorship. We also explore the groundbreaking Blood Cancer United Pediatric Acute Leukemia Master Clinical Trial (PedAL), its bold vision, global collaboration, and unified approach to data collection. Valuable clinical trial resources and strategies to support patients, families, and healthcare professionals are also shared. Tune in today!